The Feasibility and Safety of Surgery in Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Study

Immune checkpoint inhibitors (ICI) are revolutionizing care for cancer patients. The list of malignancies for which the Food and Drug Administration is granting approval is rapidly increasing. Furthermore, there is a concomitant increase in clinical trials incorporating ICI. However, the safety of I...

Descripción completa

Detalles Bibliográficos
Autores principales: Elias, Alexandra W., Kasi, Pashtoon M., Stauffer, John A., Thiel, David D., Colibaseanu, Dorin T., Mody, Kabir, Joseph, Richard W., Bagaria, Sanjay P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466999/
https://www.ncbi.nlm.nih.gov/pubmed/28660171
http://dx.doi.org/10.3389/fonc.2017.00121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466999/
https://www.ncbi.nlm.nih.gov/pubmed/28660171
http://dx.doi.org/10.3389/fonc.2017.00121

Ejemplares similares